Risk factors for seropositivity to kaposi sarcoma-associated herpesvirus among children in Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 2, 2013, Pages 228-233

  Wakeham, Katie ^a,b   Webb, Emily L ^c   Sebina, Ismail ^a   Nalwoga, Angela ^a   Muhangi, Lawrence ^a   Miley, Wendell ^d   Johnston, W Thomas ^b   Ndibazza, Juliet ^a   Whitby, Denise ^d   Newton, Robert ^a,b,e   Elliott, Alison M ^a,c  

^a Uganda Research Unit on AIDS   (Uganda)

^b UNIVERSITY OF YORK   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d SAIC FREDERICK INC   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Children; HIV; Kaposi sarcoma; Kaposi sarcoma associated herpesvirus; Sub Saharan Africa

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; UGANDA; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; KAPOSI SARCOMA; MALARIA; VIROLOGY;

VIRUS ANTIBODY;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; INFANT; MALARIA; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; UGANDA;

MLCS; MLOWN;

EID: 84879776780     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31828a7056     Document Type: Article

References (34)

1. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer. 2003;88:1-3.
2. Dollard SC, Butler LM, Graves Jones AM, et al. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-saharan Africa: insights on the origin of the "KS Belt." Int J Cancer. 2010;127:2395-2401.
3. Mbulaiteye SM, Biggar RJ, Bakaki PM, et al. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst. 2003;95:1330-1335.
4. Dedicoat M, Newton R, Alkharsah KR, et al. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis. 2004;190: 1068-1075.
5. Mbulaiteye SM, Pfeiffer RM, Engels EA, et al. Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis. 2004;190: 1382-1386.
6. Butler LM, Dollard SC, Amin M, et al. Relationship between salivary shedding and seropositivity for Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) among South African children and adults: insights on why EBV infection is ubiquitous and KSHV is not. Paper presented at: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI); April 26-27 2010; Bethesda, MD.
7. Mbulaiteye SM, Pfeiffer RM, Whitby D, et al. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis. 2003;187: 1780-1785.
8. Wakeham K, Webb EL, Sebina I, et al. Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women. Infect Agents Cancer. 2011;6:15.
9. Wabinga HR, Parkin DM, Wabwire-Mangen F, et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer. 2000; 82:1585-1592.
10. Taylor JF, Templeton AC, Vogel CL, et al. Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer. 1971;8:122-135.
11. Elliott AM, Kizza M, Quigley MA, et al. The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]. Clin Trials. 2007;4:42-57.
12. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14:397-400.
13. Bukusuba JW, Hughes P, Kizza M, et al. Screening for intestinal helminth infection in a semi-urban cohort of pregnant women in Uganda. Trop Doct. 2004;34:27-28.
14. Melrose WD, Turner PF, Pisters P, Turner B. An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg. 2000;94:176.
15. Webb EL, Mawa PA, Ndibazza J, et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:52-62.
16. Muhangi L, Woodburn P, Omara M, et al. Associations between mild-to-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, Uganda. Trans R Soc Trop Med Hyg. 2007;101:899-907.
17. Mbisa GL, Miley W, Gamache CJ, et al. Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods. 2010;356:39-46.
18. Malope BI, Pfeiffer RM, Mbisa G, et al. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr. 2007;44:351-355.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
20. Areste C, Blackbourn DJ. Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol. 2009;17:119-129.
21. Maizels RM. Parasite immunomodulation and polymorphisms of the immune system. J Biol. 2009;8(7):62.
22. Ascoli V, Facchinelli L, Valerio L, et al. Distribution of mosquito species in areas with high and low incidence of classic Kaposi's sarcoma and seroprevalence for HHV-8. Med Vet Entomol. 2006;20:198-208.
23. Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005;191:1233-1238.
24. Moormann AM, Chelimo K, Sumba PO, et al. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis. 2007;195:799-808.
25. Moormann AM, Heller KN, Chelimo K, et al. Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses. Int J Cancer. 2009;124:1721-1726.
26. Brayfield BP, Phiri S, Kankasa C, et al. Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. J Infect Dis. 2003;187:559-568.
27. Butler LM, Dorsey G, Hladik W, et al. Kaposi sarcoma-associated her-pesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis. 2009;200:430-438.
28. Malope BI, MacPhail P, Mbisa G, et al. No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS. 2008;22:519-526.
29. Brayfield BP, Kankasa C, West JT, et al. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission. J Infect Dis. 2004;189:2260-2270.
30. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, et al. Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr. 2005;38:474-479.
31. de Sanjose S, Mbisa G, Perez-Alvarez S, et al. Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis. 2009;199:1449-1456.
32. Ziegler J, Newton R, Bourboulia D, et al. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer. 2003;103:233-240.
33. McHardy J, Williams EH, Geser A, et al. Endemic Kaposi's sarcoma: incidence and risk factors in the West Nile District of Uganda. Int J Cancer. 1984;33:203-212.
34. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer. 1998;77:817-820.